R12 Calcification Drops 50ml-Similius

R12 Calcification Drops 50ml

£38.99
Add to Wishlist
Description

DR. RECKEWEG R12
Calcification Drops

Ingredients:
Arnica D3, Arsenum iodatum D4, Aurum chloratum D6, Barium chloratum D4, Calcium iodatum D3, Conium D5, Glonoinum D6, Kalium iodatum D3, Plumbum aceticum D6, Phosphorus D5

Indications:
• General arteriosclerosis
• Hypertonia
• Cerebral, aortic, and coronary sclerosis
• Nephrosclerosis
• Senility
• Weak memory
• Blood congestion
• Vertigo
• Forgetfulness
• Tendency towards apoplexy and its consequences
• Predisposition to goitre and thyrotoxicosis

Mode of Action:
Extended iodine therapy using different iodates combined with active biological agents.

Arnica: Apoplexy tendency
Aurum chloratum: Depressive psychosis; cranial blood congestion; palpitations
Barium chloratum: Memory loss, unsteadiness, psychic disturbances, vertigo, deafness, senility
Conium: Vertigo, memory loss, impotence
Iodates: Influence blood viscosity and thyroid function; act on general arteriosclerosis
Glonoinum: Cranial congestion, strong pulse, chest/heart oppression
Phosphorus: Vertigo (esp. on rising), cranial blood congestion, memory loss, mental changes, nervous system weakness, hypersensitivity
Plumbum aceticum: Pale hypertension with dementia; renal vascular disease; intermittent claudication

Dosage:
General use: 10–15 drops in water, 3 times daily
Acute cases: 10–15 drops 4–6 times daily at treatment onset
Maintenance: After 2–3 weeks of improvement, continue 1–2 times daily
Salt should be avoided during treatment; small amounts may be reintroduced after improvement

Special Indications:
Goitre/thyrotoxicosis predisposition: 10–15 drops once daily for 4–6 weeks; repeat monthly
Apoplexy: 10–15 drops every 1–2 hours initially, then 4–6 times daily

Remarks:
With cardiac weakness: alternate R12 and R3, 2–3 times daily
Myocardial infarct: see R67 and R2
Angina pectoris: alternate with R2
Cardiac insufficiencies: see R3
Cardiac decompensation: see R58
Vertigo: alternate with R29
Intermittent claudication/peripheral vascular issues: see R63